Kikaku America International
Background on Kikaku America International’s Trend Reports
Kikaku America International’s (Kikaku) report data have typically been used as reference materials by health care payers, providers, associations, consultants, strategists, employers and policy analysts to help them stay abreast of trends, conduct business and long-term planning. These individuals typically use the data to compare or benchmark their own organizations’ data against broader industry performance.
About Kikaku America International
Kikaku is a consulting firm that specializes in health care. Kikaku focuses on assisting healthcare companies and providers with business development, licensing opportunities, analysis and reports focused on such issues as managed care, neurology, gastroenterology, dermatology, eye care and senior care.
Kikaku was started in January, 1986 by Mr. Michael Sonnenreich, President & CEO, Kikaku America International and his Japanese partner, Mr. Hiro Yamagata.
PharMa International, is Kikaku America International's sister company in Tokyo and Osaka, Japan. PharMa International is a leading health care communications company in Japan.
Along with its unique network of legal, medical, and business representatives and consultants, Kikaku provides its clients with creative advertising and promotional services. With its American expertise and its understanding of the needs of Japanese pharmaceutical companies, Kikaku offers a unique service tailored to the needs of international and Japanese pharmaceutical companies, focusing on the specialized planning required by pharmaceutical, diagnostics, and device manufacturers to ensure the success of those preparing to enter the United States marketplace, and those who are currently doing business in the United States marketplace and globally.
Kikaku has consulted on starting new business and expanding on existing business with dozens of companies such as Takeda Pharmaceuticals North America Inc., Otsuka America Pharmaceuticals, Inc., Eisai Inc., Astellas Pharma US, Inc., Shionogi USA, Inc., Maruho Co., Ltd, Nitto Medic Co., Ltd., Rohto Pharmaceutical Co., Ltd., Teikoku Seiyaku Co., Ltd. and others.
The Kikaku Unique Network also includes strong relationships with third party payers and providers, and these relationships allow Kikaku to produce publications that are highly valued by these audiences.
The publications include:
The Prescription Drug Benefit Cost and Plan Design Survey Report Provided by Takeda
The UCB Parkinson’s Report: for Managed Care, Neurology & Senior Care Decision-Makers
Chronic Pain Care Trends: Perspectives from Managed Care, Providers, and Employers
The Galderma Quality Report for Dermatology and Managed Care, Vol. II
The Ferring Managed Care Trend Report for Infertility
The Ferring Managed Care Trend Report for Osteoarthritis
The Boehringer Ingelheim Pharmacy Benefits Report
The Boehringer Ingelheim Medicare Part D & Patient-Centered Medical Home Report
The Multiple Sclerosis Trend Report: Perspectives from Managed Care, Providers, and Patients (sponsored by Teva Neuroscience & the National MS Society from 2006 to the present)
Sanofi-aventis Senior Care Digest Interdisciplinary Report: A Survey of Long-Term-Care Health Professionals
Sanofi-aventis Oncology Cancer Care Report (5 regional reports)
Sanofi-aventis Atrial Fibrillation Data Brief (6 regional reports)
Biologics Trend Report Sponsored by UCB
The Maruho Derma Report (newsletter for 2,000 Japanese dermatologists)
The American College of Allergy, Asthma & Immunology Practice Management Update (newsletter)
The Novo Nordisk Diabetes Care Report: Partnering To Address Diabetes
Management in Long-Term Care (Newsletter)
Renew Advantage Aesthetic Dermatology and Plastic Surgery Loyalty Trend Report
The Eye Care Trend Report Supported By Allergan
The Ferring Pharmaceuticals Gastroenterology Practice Management Report
The Alcohol and Opioid Addiction Trend Report sponsored by Alkermes
Published newsletters include:
The Maruho Derma Report (newsletter for a few thousand Japanese dermatologists)
Novo Nordisk Diabetes Care Report
ACAAI Practice Management Update
The National Psoriasis Foundation Reports on the 2016 AAD Meeting, Supported by Novartis
Novo Nordisk Best Practices in Diabetes Management: Spotlight on Rapid-Acting Insulin Analogs
Novo Nordisk Best Practices in Diabetes Management: Spotlight on Long-Acting Analog Basal Insulins
Novo Nordisk Best Practices in Diabetes Management: NovoRapid Bolus Insulin Helps Diabetics Fast During Ramadan
Novo Nordisk Best Practices in Diabetes Management: Spotlight on Hypoglycemia
Novo Nordisk Best Practices in Diabetes Management: Rethinking the Role of Carbohydrates
Novo Nordisk Best Practices in Diabetes Management: With Guidance, Many Diabetes Patients Can Safely Fast During Ramadan
Novo Nordisk Best Practices in Diabetes Management: Strategies To Prevent and Manage Hypoglycemia
Novo Nordisk Best Practices in Diabetes Management: New Basal Insulin Offers Flexible Dosing, Other Benefits
Building on Success: Highlights of the ACR/ARHP 2016 Annual meeting supported by Novartis
Highlights of the 2016 European Academy of Dermatology and Venereology Conference, Vienna, Austria supported by Novartis and the National Psoriasis Foundation
NOVO NORDISK BEST PRACTICES IN DIABETES MANAGEMENT: Novo Nordisk’s Tresiba® Basal Insulin Enters the Saudi Arabia Market and is Well-Received
Kikaku’s strong public relations program leads to hundreds of unsolicited requests monthly for each of the survey reports we publish. Kikaku is an independent provider of information for buyers of PBM services and for benefit plans, benefit managers, HMO/PPO pharmacy and medical directors, and chain drug store decision-makers. Kikaku mails survey questionnaires to get the comments and reactions of health-care professionals, such as medical directors, consultant pharmacists, directors of nursing, geriatric nurse practitioners, employers, HMO/PPO medical directors, pharmacy directors, PBM/mail service patients, and other medical and advocacy related groups. The reports then are distributed at specified national health-care meetings and conventions, and to major MCOs, PBMs, and employers. We personally organize presentations about on our reports, free of charge, to be given at many important managed care meetings for the purpose of answering questions and promoting the reports. These meetings are well attended. Kikaku also receives favorable major media exposure for all its reports.
In addition to preparing highly successful survey reports, Kikaku conducts a NETsendex program. This involves analyzing the web sites of its pharmaceutical clients on a monthly basis to determine the search engine visibility and ranking of their products as compared to those of their competitors, and to make recommendations where needed to increase their product rankings along with awareness and viewership of their web sites.
What sets us apart from other companies that publish reports or enduring education materials is our expertise in creating successful trend reports.
Background on Peter Sonnenreich
Peter Sonnenreich is President and Chief Executive Officer of Kikaku America International. With offices in Washington, D.C., and Boston, Kikaku provides healthcare consulting and analysis to health plans, providers, and the pharmaceutical industry. Sonnenreich is a director of PharMa International, Tokyo, Japan. Sonnenreich has served as a Board Member of Les Aliments SoYummi, Inc a food company. He also served as the Vice President, Pharmaceutical Sales at LaserLock Technologies, a company that authenticates products for the pharmaceutical industry.
Before joining Kikaku Peter was a Searle Fellow in the Federal Affairs Department of the Pharmaceutical Research & Manufacturers of America (PhRMA), Mr. Sonnenreich analyzed congressional bills affecting the pharmaceutical industry. He came to PhRMA after his association with Searle Pharmaceuticals in Skokie, Illinois, where he was an associate managed care analyst and coordinated the company’s pharmaceutical sales to mail service and pharmacy benefit management companies. In addition to his work with federal legislation and managed care, Mr. Sonnenreich has worked in the areas of public policy, market research, dermatology and ophthalmology business development. He received a master’s degree in public policy and citizen participation at Tufts University. Peter was awarded the Gold Triangle Award, from the American Academy of Dermatology three times for dermatology reports and writing. He has also won the APEX Award and the Hermes Platinum Creative Awards consistently over the years for the trend reports that he has published for the pharmaceutical industry.